Last $0.38 HKD
Change Today 0.00 / 0.00%
Volume 88.0K
As of 4:01 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

tianda pharmaceuticals ltd (455) Snapshot

Open
$0.37
Previous Close
$0.38
Day High
$0.38
Day Low
$0.37
52 Week High
03/11/14 - $0.50
52 Week Low
08/8/13 - $0.30
Market Cap
701.3M
Average Volume 10 Days
409.7K
EPS TTM
$0.18
Shares Outstanding
1.9B
EX-Date
09/17/13
P/E TM
2.0x
Dividend
$0.0041
Dividend Yield
1.09%
Current Stock Chart for TIANDA PHARMACEUTICALS LTD (455)

Related News

No related news articles were found.

tianda pharmaceuticals ltd (455) Related Businessweek News

No Related Businessweek News Found

tianda pharmaceuticals ltd (455) Details

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products. Its principal product is Cerebroprotein Hydrolysate injection for treating craniocerebral trauma, and improving sequelae of cerebrovascular and deficiency of brain function, as well as for patients who lack protein or with neurasthenia. The company also provides ZhiKang granule for improving blood circulation and eliminating vascular plaques; Valsartan capsule, an antihypertensive drug; and Aceglutamide injection for traumatic brain injury coma, coma caused by nerve surgery, hepatic coma and paralysis, paraplegia, polio sequelae, nervous headache, low back pain, etc. It operates in the People’s Republic of China, Hong Kong, and Australia. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. Tianda Pharmaceuticals Limited is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

516 Employees
Last Reported Date: 12/16/13

tianda pharmaceuticals ltd (455) Top Compensated Officers

Chairman, Managing Director, Chairman of Nomi...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

tianda pharmaceuticals ltd (455) Key Developments

Tianda Pharmaceuticals Limited Reports Unaudited Consolidated Cash Flow Results for the Six Months Ended September 30, 2013

Tianda Pharmaceuticals Limited reported unaudited consolidated cash flow results for the six months ended September 30, 2013. For the period, the company reported net cash from operating activities of HKD 34,848,906 compared with HKD 96,106,834 a year ago. Additions to property, plant and equipment in the current interim period amounted to HKD 3,064,335 against HKD 3,625,621 a year ago.

Tianda Pharmaceuticals Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2013

Tianda Pharmaceuticals Limited reported unaudited consolidated earnings results for the six months ended September 30, 2013. For the period, the company's revenue was HKD 124.3 million compared with HKD 67.3 million a year ago. Profit before tax was HKD 39.8 million compared with HKD 29.95 million a year ago. Profit for the period from continuing operations was HKD 31.8 million compared with HKD 25.3 million a year ago. Profit for the period was HKD 31.8 million compared with HKD 42.2 million a year ago. Profit for the period attributable to the owners of the company from continuing operations was HKD 15.8 million or 0.84 HKD cents per basic share compared with HKD 11.2 million or 0.60 HKD cents per basic share a year ago. Profit for the period attributable to the owners of the company was HKD 15.8 million or 0.84 HKD cents per basic share compared with HKD 24.6 million or 1.31 HKD cents per basic share a year ago.

Tianda Pharmaceuticals Limited to Report First Half, 2014 Results on Nov 26, 2013

Tianda Pharmaceuticals Limited announced that they will report first half, 2014 results on Nov 26, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
455:HK $0.38 HKD 0.00

455 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 455.
View Industry Companies
 

Industry Analysis

455

Industry Average

Valuation 455 Industry Range
Price/Earnings 23.9x
Price/Sales 2.9x
Price/Book 0.9x
Price/Cash Flow 23.9x
TEV/Sales 0.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANDA PHARMACEUTICALS LTD, please visit www.tiandapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.